1990
DOI: 10.1159/000248005
|View full text |Cite
|
Sign up to set email alerts
|

Topical Ciclosporin in Nail Psoriasis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
18
0
1

Year Published

2000
2000
2018
2018

Publication Types

Select...
5
3
2

Relationship

0
10

Authors

Journals

citations
Cited by 41 publications
(22 citation statements)
references
References 1 publication
3
18
0
1
Order By: Relevance
“…Similarly, topical cyclosporine also showed impressive clearing of nail pitting and onycholysis, but the lone study was based on the lesions of only one patient. 91 In general, topical therapies appear to be an easy and relatively effective form of treatment for nail psoriasis, especially with respect to subungual hyperkeratosis, but lack convincing evidence for other dystrophies. Even though the use of topical medications is safe and effective on specific nail dystrophies, there still remains a legitimate need for more wellcontrolled and well-documented studies within the literature.…”
Section: Conclusion and Future Trendsmentioning
confidence: 99%
“…Similarly, topical cyclosporine also showed impressive clearing of nail pitting and onycholysis, but the lone study was based on the lesions of only one patient. 91 In general, topical therapies appear to be an easy and relatively effective form of treatment for nail psoriasis, especially with respect to subungual hyperkeratosis, but lack convincing evidence for other dystrophies. Even though the use of topical medications is safe and effective on specific nail dystrophies, there still remains a legitimate need for more wellcontrolled and well-documented studies within the literature.…”
Section: Conclusion and Future Trendsmentioning
confidence: 99%
“…In 1990, Tosti et al 70 reported clinical improvement in nail psoriasis following application of topical cyclosporine to the proximal nailfold for 3 months. Similarly, efficacy was demonstrated in a recent randomized placebo-controlled trial of topical cyclosporine.…”
Section: Therapeutic Implicationsmentioning
confidence: 99%
“…Dithranol may have antiproliferative and anti-inflammatory properties, and short contact treatment with the drug for 5 months appeared to be effective in treating psoriatic nail bed dystrophies and, to a lesser extent, matrix disease (table I), [10] although the local irritation and temporary nail staining associated with dithranol may not be acceptable to some patients. [12] Its efficacy has since been confirmed in a vehicle-controlled study [11] (table I). [12] Its efficacy has since been confirmed in a vehicle-controlled study [11] (table I).…”
Section: Studies Of Fluorouracilmentioning
confidence: 88%